Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RxSight Inc. Common Stock
RXST | US
4.94
USD-0.30
-5.73%
RXST | US
Loading StockChartView...
About RxSight Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
02/06/2026
Close
4.94
Open
5.22
High
5.28
Low
4.93
RxSight Inc. an ophthalmic medical device company engages in the research and development manufacture and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision Inc. and changed its name to RxSight Inc. in February 2017. RxSight Inc. was incorporated in 1997 and is headquartered in Aliso Viejo California.
View LessRXST | US
Risk
68.9
Sharpe
-0.99
Luna's Score
45/100
Recommendation
Sell
Luna says (RXST | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
53.7%1 month
68.9%3 months
62.5%6 months
62.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
108.70
Price to book
7.21
Debt to equity
0.04
Debt to assets
0.04
Ent. to EBITDA
-7.70
Ent. to rev.
15.31
PEG
-
Other Fundamentals
EBITDA
-38.31M
MarketCap
196.03M
MarketCap(USD)
196.03M
Div. yield
-
Op. margin
-23.89
Erngs. growth
-
Rev. growth
67.60
Ret. on equity
-17.01
Short ratio
4.84
Short perc.
5.97
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.60
Range1M
2.56
Range3M
3.15
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.31
Price X volume
5.32M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.70 | 46.09 | Cheaper |
| Ent. to Revenue | 15.31 | 14.34 | Par |
| PE Ratio | - | 30.41 | - |
| Price to Book | 7.21 | 6.21 | Par |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 62.48 | 64.12 | Par |
| Debt to Equity | 0.04 | -145.53 | Expensive |
| Debt to Assets | 0.04 | 0.35 | Cheaper |
| Market Cap | 196.03M | 9.70B | Emerging |
